<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Evolent Health Inc — News on 6ix</title>
<link>https://6ix.com/company/evolent-health-inc</link>
<description>Latest news and press releases for Evolent Health Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 07 Apr 2026 20:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/evolent-health-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835652578dffbe2df0eff4b.webp</url>
<title>Evolent Health Inc</title>
<link>https://6ix.com/company/evolent-health-inc</link>
</image>
<item>
<title>Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-to-release-first-quarter-2026-financial-results-on-thursday-may-7-2026</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-to-release-first-quarter-2026-financial-results-on-thursday-may-7-2026</guid>
<pubDate>Tue, 07 Apr 2026 20:30:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its first quarter 2026 financial results on Thursday, May 7, 2026, before market open, with a conference call to follow at 8 a.m. ET.</description>
</item>
<item>
<title>Evolent announces appointment of Archie Mayani as chief product officer</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-announces-appointment-of-archie-mayani-as-chief-product-officer</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-announces-appointment-of-archie-mayani-as-chief-product-officer</guid>
<pubDate>Thu, 19 Mar 2026 12:45:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced the appointment of health care technology leader and AI innovator Archie Mayani as chief product officer (CPO).</description>
</item>
<item>
<title>Evolent to Participate in Upcoming Investor Conferences</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-to-participate-in-upcoming-investor-conferences</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-to-participate-in-upcoming-investor-conferences</guid>
<pubDate>Thu, 26 Feb 2026 22:00:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced that members of its executive management team will participate in upcoming investor conferences.</description>
</item>
<item>
<title>Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-announces-fourth-quarter-2025-results-and-full-year-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-announces-fourth-quarter-2025-results-and-full-year-2025-results</guid>
<pubDate>Tue, 24 Feb 2026 21:10:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended December 31, 2025.</description>
</item>
<item>
<title>Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-release-2025-fourth-quarter-160200561</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-release-2025-fourth-quarter-160200561</guid>
<pubDate>Wed, 04 Feb 2026 16:02:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its 2025 fourth quarter and year-end financial results on Tuesday, February 24, 2026, after market close, with a conference call to follow at 5 p.m. ET.</description>
</item>
<item>
<title>Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-reports-inducement-award-under-211500354</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-reports-inducement-award-under-211500354</guid>
<pubDate>Fri, 02 Jan 2026 21:15:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, announced that the Compensation Committee of Evolent's Board of Directors approved the grant of a one-time time-based restricted stock unit award covering 587,500 shares of Evolent Class A common stock, par value $0.01 per share (the "Inducement Award"), to Mr. Mario Ramos</description>
</item>
<item>
<title>Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-american-oncology-network-unveil-211200613</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-american-oncology-network-unveil-211200613</guid>
<pubDate>Thu, 06 Nov 2025 21:12:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AON), one of the nation's fastest-growing community oncology networks, today announced a new model enabling high-quality, more affordable, and connected cancer care — all without relying on prior authorization.</description>
</item>
<item>
<title>Evolent Announces Third Quarter 2025 Results</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-announces-third-quarter-2025-211000323</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-announces-third-quarter-2025-211000323</guid>
<pubDate>Thu, 06 Nov 2025 21:10:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended September 30, 2025.</description>
</item>
<item>
<title>Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-release-third-quarter-2025-123000872</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-release-third-quarter-2025-123000872</guid>
<pubDate>Thu, 09 Oct 2025 12:30:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after market close, with a conference call to follow at 5 p.m. ET.</description>
</item>
<item>
<title>Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-announces-strategic-divestiture-value-201000754</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-announces-strategic-divestiture-value-201000754</guid>
<pubDate>Tue, 23 Sep 2025 20:10:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced that it has agreed to sell its value-based primary care business, Evolent Care Partners ("ECP"), to Privia Health Group, Inc. (Nasdaq: PRVA). ECP is a leading participant in the Medicare Shared Savings Program ("MSSP"), partnering with more than 1,000 physicians across the nation to serve more than 120,000 members.</description>
</item>
<item>
<title>[solidcore] Adds New Leadership and Board Expertise Amid Strong Growth</title>
<link>https://6ix.com/company/evolent-health-inc/news/solidcore-adds-new-leadership-and-board-expertise-amid-strong-growth</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/solidcore-adds-new-leadership-and-board-expertise-amid-strong-growth</guid>
<pubDate>Tue, 09 Sep 2025 17:00:00 GMT</pubDate>
<description>WASHINGTON, September 09, 2025--[solidcore], the targeted strength training brand, today announced the appointment of two new C-suite executives and a new member of its Board of Directors. The additions, which include the company’s first Chief People Officer and Chief Commercial Officer, come as [solidcore] expands to more than 150 studios nationwide and continues to strengthen its position as a category leader in boutique fitness.</description>
</item>
<item>
<title>Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-health-inc-announces-pricing-110000954</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-health-inc-announces-pricing-110000954</guid>
<pubDate>Tue, 19 Aug 2025 11:00:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced the pricing of $145.0 million aggregate principal amount of 4.50% convertible senior notes due 2031. The notes are being offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Evolent has also granted the initial purchasers in the</description>
</item>
<item>
<title>Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-health-inc-announces-proposed-200500657</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-health-inc-announces-proposed-200500657</guid>
<pubDate>Mon, 18 Aug 2025 20:05:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced that it intends to offer $140.0 million aggregate principal amount of convertible senior notes due 2031, subject to market and other conditions. Evolent also expects to grant the initial purchasers in the proposed offering an option to purchase up to an additional $20.0 million aggregate principal amount of notes. The notes are being offered only</description>
</item>
<item>
<title>Evolent Announces Second Quarter 2025 Results</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-announces-second-quarter-2025-201000020</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-announces-second-quarter-2025-201000020</guid>
<pubDate>Thu, 07 Aug 2025 20:10:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended June 30, 2025.</description>
</item>
<item>
<title>Ashley Snyder Joins Medical Home Network as Chief Development Officer to Lead Partnership Efforts</title>
<link>https://6ix.com/company/evolent-health-inc/news/ashley-snyder-joins-medical-home-network-as-chief-development-officer-to-lead-partnership-efforts-1</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/ashley-snyder-joins-medical-home-network-as-chief-development-officer-to-lead-partnership-efforts-1</guid>
<pubDate>Wed, 23 Jul 2025 14:03:00 GMT</pubDate>
<description>Medical Home Network (MHN), a mission-driven organization enabling federally qualified health centers (FQHCs) nationwide to succeed in value-based care, today announced the appointment of Ashley Snyder as its first Chief Development Officer.</description>
</item>
<item>
<title>Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-release-second-quarter-2025-120000042</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-release-second-quarter-2025-120000042</guid>
<pubDate>Mon, 14 Jul 2025 12:00:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2025 financial results on Thursday, August 7, 2025, after market close, with a conference call to follow at 5 p.m. ET.</description>
</item>
<item>
<title>Evolent announces key appointments to leadership team</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-announces-key-appointments-leadership-120000926</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-announces-key-appointments-leadership-120000926</guid>
<pubDate>Wed, 09 Jul 2025 12:00:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced leadership additions to its clinical and financial teams, as it continues to drive innovation in specialty care.</description>
</item>
<item>
<title>Evolent reiterates Q2 and full year guidance for Adjusted EBITDA</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-reiterates-q2-full-guidance-103000791</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-reiterates-q2-full-guidance-103000791</guid>
<pubDate>Fri, 20 Jun 2025 10:30:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced that based on leading indicators and paid claims data through May, it continues to experience oncology cost trend below expectations coming into 2025. Evolent is reiterating its Q2 2025 Adjusted EBITDA guidance of $33M-$40M and its full year Adjusted EBITDA guidance of $135M-165M.</description>
</item>
<item>
<title>Evolent Announces First Quarter 2025 Results</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-announces-first-quarter-2025-201000494</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-announces-first-quarter-2025-201000494</guid>
<pubDate>Thu, 08 May 2025 20:10:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended March 31, 2025.</description>
</item>
<item>
<title>Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors</title>
<link>https://6ix.com/company/evolent-health-inc/news/evolent-names-shawn-guertin-independent-103000239</link>
<guid isPermaLink="true">https://6ix.com/company/evolent-health-inc/news/evolent-names-shawn-guertin-independent-103000239</guid>
<pubDate>Tue, 22 Apr 2025 10:30:00 GMT</pubDate>
<description>Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced that a new director nominee will stand for election to the Board of Directors at the annual meeting of stockholders scheduled to be held on June 5, 2025.</description>
</item>
</channel>
</rss>